{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:09:09Z","timestamp":1792786149634,"version":"4.5.0"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","license":[{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/ http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Georg C. and Mary Ehrnrooth Foundation"},{"name":"The Finnish Medical Foundation","id":[{"id":"https:\/\/ror.org\/0593mby10","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Suorsa Healthcare Foundation"},{"name":"Sigrid Jus\u00e9lius Foundation","id":[{"id":"https:\/\/ror.org\/00ckakm23","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Sigrid Jus\u00e9lius Foundation","id":[{"id":"https:\/\/ror.org\/00ckakm23","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Finnish Cultural Foundation","id":[{"id":"https:\/\/ror.org\/027xav248","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Cancer Foundation Finland","id":[{"id":"https:\/\/ror.org\/0113k5861","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Cancer Foundation Finland","id":[{"id":"https:\/\/ror.org\/0113k5861","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Finnish State Research"},{"name":"Finnish State Research"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:p>\n                    Colon cancer is a major global malignancy with significant mortality. Right-sided (RCC) and left-sided colon cancers (LCC) exhibit distinct clinicopathological characteristics. Tumor microenvironment score (TMS) combines Klintrup-M\u00e4kinen grade, tumor stroma percentage, and tumor budding, classifying cases into 4 groups (TMS 0-3). Evaluation of TMS is an integrative method for prognostic classification; however, further validation is needed, and differences between RCC and LCC remain unclear. A discovery cohort (n=940) and a validation cohort (n=613) were retrospectively included. TMS was evaluated from hematoxylin-eosin-stained slides. Five-year disease-specific survival (DSS) was analyzed using life-table methods and Cox regression. Associations with clinicopathological variables were assessed. In both the discovery and validation cohorts, higher TMS was associated with worse 5-year DSS in univariable analyses for both RCC and LCC. In multivariable analysis, high TMS (TMS3 vs. TMS0) remained independently associated with survival in the discovery cohort (RCC\u2014HR: 2.47, 95% CI: 1.36-4.46,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    =0.003; LCC\u2014HR: 3.08, 95% CI: 1.46-6.45,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    =0.003). In the validation cohort, the prognostic impact of TMS was more pronounced in RCC (HR: 4.35, 95% CI: 2.32-8.14,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    &lt;0.001) than in LCC (HR: 2.21, 95% CI: 0.81-6.03,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    =0.12). TMS also appeared to provide improved prognostic stratification compared with the Glasgow microenvironment score (combination of Klintrup-M\u00e4kinen grade and tumor stroma percentage). In conclusion, TMS serves as an integrative histopathological marker with potential to improve prognostic stratification in colon cancer, particularly in right-sided tumors.\n                  <\/jats:p>","DOI":"10.1097\/pas.0000000000002599","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T06:00:12Z","timestamp":1787637612000},"page":"1333-1341","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["The Tumor Microenvironment Score and Its Subsite-Specific Relevance in Colon Cancer"],"prefix":"10.1097","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-3175-5956","authenticated-orcid":false,"given":"Mari J.","family":"Jawad","sequence":"first","affiliation":[{"name":"Translational Medicine Research Unit, Medical Research Center Oulu, Oulu University Hospital, and University of Oulu"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vilja V.","family":"Tapiainen","sequence":"additional","affiliation":[{"name":"Translational Medicine Research Unit, Medical Research Center Oulu, Oulu University Hospital, and University of Oulu"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ville K.","family":"\u00c4ij\u00e4l\u00e4","sequence":"additional","affiliation":[{"name":"Translational Medicine Research Unit, Medical Research Center Oulu, Oulu University Hospital, and University of Oulu"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e4ivi H.","family":"Sirni\u00f6","sequence":"additional","affiliation":[{"name":"Translational Medicine Research Unit, Medical Research Center Oulu, Oulu University Hospital, and University of Oulu"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne E.","family":"Tuomisto","sequence":"additional","affiliation":[{"name":"Translational Medicine Research Unit, Medical Research Center Oulu, Oulu University Hospital, and University of Oulu"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Elomaa","sequence":"additional","affiliation":[{"name":"Research Program in Systems Oncology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarit","family":"Ahtiainen","sequence":"additional","affiliation":[{"name":"Central Finland Biobank, Hospital Nova of Central Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olli","family":"Helminen","sequence":"additional","affiliation":[{"name":"Translational Medicine Research Unit, Medical Research Center Oulu, Oulu University Hospital, and University of Oulu"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erkki-Ville","family":"Wirta","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Alimentary Tract Surgery"},{"name":"Center for Cancer Eradication Research, Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Tampere University Hospital, Tampere, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toni T.","family":"Sepp\u00e4l\u00e4","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, Helsinki University Central Hospital"},{"name":"Applied Tumour Genomics, Research Program Unit, University of Helsinki, Helsinki"},{"name":"Center for Cancer Eradication Research, Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, Tampere University Hospital, Tampere, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"B\u00f6hm","sequence":"additional","affiliation":[{"name":"Department of Pathology, Hospital Nova of Central Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jukka-Pekka","family":"Mecklin","sequence":"additional","affiliation":[{"name":"Department of Education and Research, Well Being Services County of Central Finland"},{"name":"Faculty of Sport and Health Sciences, University of Jyv\u00e4skyl\u00e4, Jyv\u00e4skyl\u00e4"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henna","family":"Karjalainen","sequence":"additional","affiliation":[{"name":"Translational Medicine Research Unit, Medical Research Center Oulu, Oulu University Hospital, and University of Oulu"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meeri","family":"Kastinen","sequence":"additional","affiliation":[{"name":"Translational Medicine Research Unit, Medical Research Center Oulu, Oulu University Hospital, and University of Oulu"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timo","family":"V\u00e4is\u00e4nen","sequence":"additional","affiliation":[{"name":"Department of Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vesa-Matti J.","family":"Pohjanen","sequence":"additional","affiliation":[{"name":"Translational Medicine Research Unit, Medical Research Center Oulu, Oulu University Hospital, and University of Oulu"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus J.","family":"M\u00e4kinen","sequence":"additional","affiliation":[{"name":"Translational Medicine Research Unit, Medical Research Center Oulu, Oulu University Hospital, and University of Oulu"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jukka M.","family":"Rintala","sequence":"additional","affiliation":[{"name":"Translational Medicine Research Unit, Medical Research Center Oulu, Oulu University Hospital, and University of Oulu"},{"name":"Department of Surgery, Oulu University Hospital, Oulu"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heikki","family":"Huhta","sequence":"additional","affiliation":[{"name":"Translational Medicine Research Unit, Medical Research Center Oulu, Oulu University Hospital, and University of Oulu"},{"name":"Department of Surgery, Oulu University Hospital, Oulu"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juha P.","family":"V\u00e4yrynen","sequence":"additional","affiliation":[{"name":"Translational Medicine Research Unit, Medical Research Center Oulu, Oulu University Hospital, and University of Oulu"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,8,25]]},"reference":[{"key":"R1-20261014","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"R2-20261014","doi-asserted-by":"crossref","first-page":"5356","DOI":"10.3390\/curroncol28060447","article-title":"Pathological features and prognostication in colorectal cancer","volume":"28","author":"Chen","year":"2021","journal-title":"Curr Oncol"},{"key":"R3-20261014","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/S0140-6736(19)32319-0","article-title":"Colorectal cancer","volume":"394","author":"Dekker","year":"2019","journal-title":"Lancet"},{"key":"R4-20261014","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/S0140-6736(18)30789-X","article-title":"International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study","volume":"391","author":"Pag\u00e8s","year":"2018","journal-title":"Lancet"},{"key":"R5-20261014","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1038\/nm.3967","article-title":"The consensus molecular subtypes of colorectal cancer","volume":"21","author":"Guinney","year":"2015","journal-title":"Nat Med"},{"key":"R6-20261014","doi-asserted-by":"crossref","first-page":"e12374","DOI":"10.1002\/2056-4538.12374","article-title":"Histopathological tumour microenvironment score independently predicts outcome in primary operable colorectal cancer","volume":"10","author":"Hatthakarnkul","year":"2024","journal-title":"J Pathol Clin Res"},{"key":"R7-20261014","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3390\/cancers12020319","article-title":"Prognostic and predictive molecular biomarkers for colorectal cancer: updates and challenges","volume":"12","author":"Koncina","year":"2020","journal-title":"Cancers"},{"key":"R8-20261014","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1016\/j.ejca.2005.07.017","article-title":"Inflammation and prognosis in colorectal cancer","volume":"41","author":"Klintrup","year":"2005","journal-title":"Eur J Cancer"},{"key":"R9-20261014","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00428-018-2408-z","article-title":"Scoring the tumor-stroma ratio in colon cancer: procedure and recommendations","volume":"473","author":"van Pelt","year":"2018","journal-title":"Virchows Arch"},{"key":"R10-20261014","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/modpathol.2017.46","article-title":"Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016","volume":"30","author":"Lugli","year":"2017","journal-title":"Mod Pathol"},{"key":"R11-20261014","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1158\/1078-0432.CCR-14-1686","article-title":"Evaluation of a tumor microenvironment-based prognostic score in primary operable colorectal cancer","volume":"21","author":"Park","year":"2015","journal-title":"Clin Cancer Res"},{"key":"R12-20261014","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1158\/1078-0432.CCR-17-2484","article-title":"Classifying colorectal cancer by tumor location rather than sidedness highlights a continuum in mutation profiles and consensus molecular subtypes","volume":"24","author":"Loree","year":"2018","journal-title":"Clin Cancer Res"},{"key":"R13-20261014","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.annonc.2022.10.003","article-title":"Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up \u2606","volume":"34","author":"Cervantes","year":"2023","journal-title":"Annals of Oncology"},{"key":"R14-20261014","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.annonc.2020.06.022","article-title":"Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"31","author":"Argil\u00e9s","year":"2020","journal-title":"Annals of Oncology"},{"key":"R15-20261014","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1053\/j.gastro.2009.12.064","article-title":"Microsatellite instability in colorectal cancer","volume":"138","author":"Boland","year":"2010","journal-title":"Gastroenterology"},{"key":"R16-20261014","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41698-025-00892-y","article-title":"Multidimensional differences of right- and left-sided colorectal cancer and their impact on targeted therapies","volume":"9","author":"Abdel Hamid","year":"2025","journal-title":"NPJ Precis Oncol"},{"key":"R17-20261014","doi-asserted-by":"crossref","first-page":"e1098801","DOI":"10.1080\/2162402X.2015.1098801","article-title":"Comparison of the prognostic value of measures of the tumor inflammatory cell infiltrate and tumor-associated stroma in patients with primary operable colorectal cancer","volume":"5","author":"Park","year":"2016","journal-title":"Oncoimmunology"},{"key":"R18-20261014","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1200\/JCO.21.02538","article-title":"Adjuvant therapy for stage II colon cancer: ASCO Guideline update","volume":"40","author":"Baxter","year":"2022","journal-title":"J Clin Oncol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/PAS.0000000000002599","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T07:00:12Z","timestamp":1791961212000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/PAS.0000000000002599"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,25]]},"references-count":18,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000002599","relation":{},"ISSN":["0147-5185","1532-0979"],"issn-type":[{"value":"0147-5185","type":"print"},{"value":"1532-0979","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,25]]},"assertion":[{"value":"2026-05-27","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-29","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}